Ophthalmic composition

Details Ophthalmic composition Ophthalmic composition

A - Human Necessities

61

K

A61K 31/58 (2006.01) A61K 31/56 (2006.01) A61K 31/565 (2006.01) A61K 31/57 (2006.01) A61K 31/665 (2006.01) C07J 3/00 (2006.01) C07J 5/00 (2006.01) C07J 9/00 (2006.01) C07J 11/00 (2006.01) C07J 41/00 (2006.01) C07J 51/00 (2006.01)

Patent

CA 2064478

Pharmaceutical compositions useful in the treatment of ophthalmic inflammation and methods of treating ophthalmic in- flammation with those compositions ar disclosed. The compositions contain a combination of a glucocorticoid and an angiostatic steroid. The angiostatic steroid substantially prevents any significant increases in intraocular pressure which might otherwise he experienced by the patient as a side effect of the glucocorticoid component of the compositions. The therapeutic interaction of the two components therefore allows the potent anti-inflammatory properties of the glucocorticoids to be utilized without fear of ele- vating intraocular pressure.

Affiliated with

Also associated with

Rating

Ophthalmic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1458546